v3.26.3
SCHEDULE OF OUTSTANDING STOCK PURCHASE WARRANTS (Details) (Paranthetical)
 12 Months Ended
Jun. 30, 2026
shares
May 2025 Series H Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrants expire date [1]
Warrants expire term 24 months
November 2025 Series J Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrants expire date [2]
Warrants expire term 18 months
November 2025 Series K Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrants expire date [3]
Warrants expire term 5 years
Stock Warrants [Member]  
Class of Warrant or Right [Line Items]  
Number of warrants 5,228
Warrants expire date Jun. 24, 2029
[1] Expire 24 months following the initial exercise date
[2] Expires the earlier of (i) the 18-month anniversary of the Initial Exercise Date if FDA IND acceptance has not been received, or (ii) 31 days after notice of FDA IND acceptance, in each case adjusted to the next Trading Day; provided that under clause (ii) the date is extended until a registration statement and prospectus are available for 30 consecutive days.
[3] Expire on the 5-year anniversary of the Initial Exercise Date, or, if the Holder’s Series J Common Stock Purchase Warrant terminates pursuant to clause (ii) thereof prior to full cash exercise, the same Termination Date as the Series J Warrant, in each case adjusted to the next Trading Day; provided that the date is extended until a registration statement and prospectus are available for 30 consecutive days following notice of FDA IND acceptance.